Yuming Li

Yuming Li

Auto-generated profile, based on publicly available information

Yuming Li

Department of Neurosurgery, the First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2024 in Cancer Research
Verified
Journal Article
Closed access
ZZZijian Zhou
Zijian Zhou
XYXianyong Yin
Xianyong Yin
HSHao Sun
Hao Sun
JLJiaze Lu
Jiaze Lu
YLYuming Li
Yuming Li
TXTao Xin
Tao Xin
Long-standing evidence implicates glioma stem cells (GSC) as the major driver for glioma propagation and recurrence. GSCs have a distinctive metabolic landscape characterized by elevated glycolysis. Lactate accumulation resulting from enhanced glycolytic activity can drive lysine lactylation to regulate protein functions, suggesting that elucidating the lactylation landscape in GSCs could provide insights into glioma biology. Herein, we have demonstrated that global lactylation was significantly elevated in GSCs compared with differentiated glioma cells. Polypyrimidine tract–binding protein 1 (PTBP1), a central regulator of RNA processing, was hyperlactylated in GSCs, and SIRT1 induced PTBP1 delactylation. PTBP1-K436 lactylation supported glioma progression and GSC maintenance. Mechanistically, K436 lactylation inhibited PTBP1 proteasomal degradation by attenuating the interaction with TRIM21. Moreover, PTBP1 lactylation enhanced RNA-binding capacity and facilitated PFKFB4 mRNA stabilization, which further increased glycolysis. Together, these findings uncovered a lactylation-mediated mechanism in GSCs driven by metabolic reprogramming that induces aberrant epigenetic modifications to further stimulate glycolysis, resulting in a vicious cycle to exacerbate tumorigenesis. Significance: Glycolysis-induced lactylation enhances the function of PTBP1 to promote glioma stem cell maintenance, indicating that PTBP1 lactylation could be a potential target for the development of innovative glioma therapies.

17 June 2026
Verified
Other
Open access
ZZZijian Zhou
Zijian Zhou
XYXianyong Yin
Xianyong Yin
HSHao Sun
Hao Sun
JLJiaze Lu
Jiaze Lu
YLYuming Li
Yuming Li
TXTao Xin
Tao Xin
Long-standing evidence implicates glioma stem cells (GSC) as the major driver for glioma propagation and recurrence. GSCs have a distinctive metabolic landscape characterized by elevated glycolysis. Lactate accumulation resulting from enhanced glycolytic activity can drive lysine lactylation to regulate protein functions, suggesting that elucidating the lactylation landscape in GSCs could provide insights into glioma biology. Herein, we have demonstrated that global lactylation was significantly elevated in GSCs compared with differentiated glioma cells. Polypyrimidine tract–binding protein 1 (PTBP1), a central regulator of RNA processing, was hyperlactylated in GSCs, and SIRT1 induced PTBP1 delactylation. PTBP1-K436 lactylation supported glioma progression and GSC maintenance. Mechanistically, K436 lactylation inhibited PTBP1 proteasomal degradation by attenuating the interaction with TRIM21. Moreover, PTBP1 lactylation enhanced RNA-binding capacity and facilitated PFKFB4 mRNA stabilization, which further increased glycolysis. Together, these findings uncovered a lactylation-mediated mechanism in GSCs driven by metabolic reprogramming that induces aberrant epigenetic modifications to further stimulate glycolysis, resulting in a vicious cycle to exacerbate tumorigenesis.Significance:Glycolysis-induced lactylation enhances the function of PTBP1 to promote glioma stem cell maintenance, indicating that PTBP1 lactylation could be a potential target for the development of innovative glioma therapies.

17 February 2025
Verified
Other
Open access
ZZZijian Zhou
Zijian Zhou
XYXianyong Yin
Xianyong Yin
HSHao Sun
Hao Sun
JLJiaze Lu
Jiaze Lu
YLYuming Li
Yuming Li
TXTao Xin
Tao Xin
Supplementary Table S1. Key reagents or resources used in this study

17 February 2025
Verified
Other
Open access
ZZZijian Zhou
Zijian Zhou
XYXianyong Yin
Xianyong Yin
HSHao Sun
Hao Sun
JLJiaze Lu
Jiaze Lu
YLYuming Li
Yuming Li
TXTao Xin
Tao Xin
Supplementary Table S3. Sequences of shRNAs or siRNAs used in this study

17 February 2025
Verified
Other
Open access
ZZZijian Zhou
Zijian Zhou
XYXianyong Yin
Xianyong Yin
HSHao Sun
Hao Sun
JLJiaze Lu
Jiaze Lu
YLYuming Li
Yuming Li
TXTao Xin
Tao Xin
Supplementary Table S4. Proteins interacting with PTBP1 determined by MS (Top100)

17 February 2025
Verified
Other
Open access
ZZZijian Zhou
Zijian Zhou
XYXianyong Yin
Xianyong Yin
HSHao Sun
Hao Sun
JLJiaze Lu
Jiaze Lu
YLYuming Li
Yuming Li
TXTao Xin
Tao Xin
This file includes: Supplementary Figures. S1 to S37 Supplementary Note S1